Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia

MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - jamanetwork.com
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …
被引用次数：108 相关文章

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

MS van Kammen, DA de Sousa, S Poli… - JAMA …, 2021 - pubmed.ncbi.nlm.nih.gov
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and …

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

M Sánchez van Kammen, D Aguiar de Sousa… - …, 2021 - digitallibrary.health.nt.gov.au
IMPORTANCE: Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and …

[引用][C] Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

M Sanchez van Kammen, D Aguiar de Sousa, S Poli… - 2021 - repository.ubn.ru.nl
IMPORTANCE: Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and …

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

M Sánchez van Kammen, D Aguiar de Sousa… - JAMA …, 2021 - boris.unibe.ch
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and …

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia.

M Sánchez van Kammen… - JAMA …, 2021 - search.ebscohost.com
Abstract Key Points: Question: What are the clinical characteristics and outcomes of patients
with cerebral venous sinus thrombosis with thrombocytopenia syndrome after SARS-CoV-2 …

Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - researchportal.helsinki.fi
Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2
Vaccine-Induced Immune Thrombotic Thrombocytopenia — University of Helsinki Skip to main …

Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

M Sánchez Van Kammen, D Aguiar De Sousa… - JAMA …, 2021 - diva-portal.org
Objective: To describe the clinical characteristics and outcome of patients with cerebral
venous sinus thrombosis (CVST) after SARS-CoV-2 vaccination with and without TTS …

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

MS van Kammen, DA de Sousa, S Poli, C Cordonnier… - JAMA neurology, 2021 - hal.science
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2
Vaccine–Induced Immune Thrombotic Thrombocytopenia - Archive ouverte HAL Accéder …

Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

M Sanchez Van Kammen, D Aguiar De Sousa… - JAMA …, 2021 - iris.unime.it
Importance: Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and …